Politics news and discussion on TalkFuse.
Time running out for young people to receive meningitis B vaccines in UK
Fewer than one in three eligible young people have received a first dose of the meningitis B vaccine offered through a one-off UK campaign. Health experts say uptake is too low, with the first-dose deadline approaching and the winter peak in infections near; the campaign follows outbreaks in Kent, Dorset and Berkshire that led to three deaths and lasting health problems for some survivors.
The UK Health Security Agency says 28.2% of eligible 18- and 19-year-olds have had a first dose, and nearly 70% of those have also received their second. Two doses at least 28 days apart are needed: eligible young people must get their first by 31 December 2026, while second doses are available until 31 March 2027. Eligibility includes those born between 1 September 2007 and 31 August 2008, and under-25s starting university or residential further education for the first time this autumn; freshers face about seven times the risk of their non-university peers.
In short
- Just 28.2% of eligible 18- and 19-year-olds have had a first dose.
- First doses must be given by 31 December.
- Experts urge stronger promotion and discuss reviewing the deadline.
Explained simply
Meningococcal disease is a serious infection that can cause meningitis, which affects the lining around the brain and spinal cord, or blood poisoning. It can spread through close contact, and meningitis B is one strain; the infection can become severe quickly.
The MenB vaccine protects against that strain. The UK campaign targets some 18- and 19-year-olds and people under 25 starting university or residential further education for the first time, where close social contact can raise the risk of infection. Two doses are needed for the course.
Elections Health Medicine Politics UK World